For instance, among two cohorts of breast cancer patients, the TMB was 2.0 to 2.6 times higher in patients with a BRCA1 or BRCA2 mutation as compared to those without a BRCA mutation [22]. This evidence concerns the gene BRCA1 and breast cancer.